T horacic aortic transection in the setting of blunt trauma has a mortality rate of 85% if left untreated. 1 Traditionally, repair of traumatic thoracic aortic transections is accomplished with a left thoracotomy, single-lung ventilation, aortic cross-clamping, and interposition grafting requiring systemic heparinization. Several studies have demonstrated mortality rates range from 5 to 28% [2] [3] [4] [5] after open repair, and paraplegia rates secondary to spinal cord ischemia range from 2.3 to 14%. 3, 6 Typically, injuries to the thoracic aorta in the setting of blunt trauma are not isolated but rather are associated with significant concomitant injuries, including closed head injury, pulmonary contusion, long-bone and pelvic fractures, and solid organ injury, making treatment of this patient population daunting. 7, 8 The complexity of these injuries and the presence of associated injuries makes the use of systemic anticoagulation problematic. Shortly after the advent of endoluminal stent-grafts used to treat thoracic aortic aneurysms by Dake et al., 9 this group applied the same endovascular technology to the treatment of traumatic thoracic aortic transection. 10 Whereas there are no specifically designed, commercially available devices used to treat traumatic thoracic aortic transections, the use of endoluminal abdominal aortic extension cuffs has been shown to be technically feasible in several small series. [11] [12] [13] [14] [15] [16] [17] Theoretical advantages of this less-invasive treatment modality include avoidance of (1) a thoracotomy, (2) need for single-lung ventilation, (3) aortic cross-clamping, (4) significant fluid shifts, and, perhaps most important, (5) systemic heparinization in these patients with multiple injuries. The purpose of this study was to demonstrate that thoracic aortic transections in the setting of blunt trauma can be treated entirely percutaneously using endoluminal stent-grafts. Herein, we report our experience in treating these injuries with commercially available endovascular aortic extension cuffs.
MATERIALS AND METHODS
Between February 2001 and February 2005, various pathologies of the thoracic aorta were treated using endovascular stent-grafts in 51 patients at Northwestern Memorial Hospital. Included in this cohort of patients were 11 (22%) endovascular procedures used to treat traumatic aortic transections. All patients suffered multiple injuries, were involved in high-speed motor vehicle collisions or rapid deceleration events, and underwent endovascular repair for thoracic aortic transection in the acute setting.
Abnormalities seen on initial chest roentgenograms ( Fig.  1 ) in the setting of blunt trauma (including widened mediastinum, obliteration of the aortic knob, tracheal deviation to the right, left hemothorax, depression of the left main stem bronchus, presence of a pleural or apical cap, widened paratracheal stripe, or fractures of the first rib or scapula) required further workup with a chest computed tomography (CT) scan. Thoracic aortic transection suggested by CT was confirmed in all cases with intraoperative aortography. Measurements of the proximal and distal neck length and aortic diameter, as well as location and extent of injury in relation to the origins of the arch vessels, were obtained using the aforementioned imaging modalities.
All procedures were performed in an operating room angiosuite, and the devices used to treat the transections consisted of commercially available endovascular aortic proximal extension cuffs (AneuRx, Medtronic/AVE, Santa Rosa, Calif; and Excluder, W.L. Gore & Associates, Flagstaff, Ariz). After the induction of general anesthesia, access to the aorta was percutaneously obtained via the common femoral artery (seven patients) or by cutdown on the femoral/ iliac artery (four patients). A floppy tipped J-wire was then passed into the aorta under direct fluoroscopic guidance. An aortogram was obtained using steep left anterior oblique projection so as to open up the aortic arch. Arch anatomy and location of the aortic transection were noted. In those patients undergoing percutaneous repair, a 10F Perclose device was then deployed using the previously described 'preclose' technique. 18 At this point, an 18F sheath was exchanged and passed proximally over a super-stiff wire. The endovascular stent-graft device was then placed over the area of transection and deployed without the use of chemically induced cardiac arrest or hypotension. An angiogram was obtained, and additional aortic extension cuffs were placed as required. Systemic heparinization was avoided in all cases.
In one patient, preoperative CT scan demonstrated the area of transection to be within close proximity to the left subclavian artery, from which the dominant vertebral artery took its origin. To ensure an adequate seal proximal to the transection in this patient, the left subclavian artery was transposed to the left common carotid artery before endovascular repair. The origin of the left subclavian artery was then covered with the stent-graft.
After endovascular repair, patients underwent CT angiography at 1 month after repair and at 6-to 12-month intervals thereafter. Mean follow-up of this patient cohort was 21 months (range, 3-49 months). This retrospective review was approved by our institution's Institutional Review Board.
RESULTS
The average patient age in this study was 43 Ϯ 14 years old (range, 20 -73 years), with seven (64%) men and four (36%) woman. Our patients suffered multiple injuries including closed head injury, rib fractures with concomitant pulmonary contusion, extremity or pelvic fractures, and solid organ injury. The mean Injury Severity Score of this group of patients was 43 Ϯ 13 (range, 25-66). The mechanisms of injury included high-speed motor vehicle collisions (nine patients), a fall from a three-story building (one patient), and a pedestrian versus automobile accident (one patient) ( Table  1) .
Endovascular repair was technically successful in 100% of patients, as determined by completion angiography at the time of the intervention (Fig. 2) . These angiograms demonstrated apposition of the stent-grafts to the aortic wall, normal perfusion of the aortic arch vessels, and exclusion of the aortic transection without evidence of extravasation of contrast in all cases. No secondary interventions were required in this patient population.
Given the severity and variety of concomitant injuries, it may not be surprising that patient outcome seemed to be determined by the associated injuries present rather than the thoracic aortic transections. There were no procedure-related deaths, and no patient suffered paralysis secondary to spinal cord ischemia. Follow-up CT scans (Fig. 3) have demonstrated technically successful endovascular repair of the traumatic aortic transections. There has been no evidence of endoleak, stent migration, or late pseudoaneurysm formation throughout follow-up.
DISCUSSION
Thoracic aortic transection in the setting of blunt trauma is often a lethal event. Left untreated, mortality rates after these injuries are estimated to be approximately 85%.
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ditional open repair via a left thoracotomy and graft interposition has mortality rates as high as 28% and paraplegia rates secondary to spinal cord ischemia of up to 14%. 3, 6 Since the initial report describing endovascular treatment of thoracic aortic pathology with stent-grafts by Kato et al., 10 several subsequent case reports have demonstrated the technical feasibility of this technique. [11] [12] [13] [14] [15] [16] [17] As the current report shows, we have demonstrated that acute aortic traumatic transection can safely and effectively be treated using 'off-the-shelf' commercially available endovascular aortic proximal extension cuffs.
The setting in which these thoracic aortic transections occurred involved high-speed motor vehicle collisions in most cases. Indeed, these injuries to the thoracic aorta were not isolated but rather occurred in the setting of multisystem trauma. Unlike traditional open repair, endovascular treatment of thoracic aortic transections obviates the need for systemic anticoagulation. The avoidance of systemic heparinization in this patient population suffering multiple injuries, including long-bone or pelvic fractures and solid organ injury, is an important theoretical advantage of endovascular repair over open repair. Additionally, the more minimally invasive endovascular repair of these aortic injuries has the potential for significantly reduced iatrogenic blood loss in comparison to open repair. The importance of these advantages in patients with multiple injuries, who are often hemodynamically unstable, cannot be overstated. Whereas there are no commercially available devices designed specifically for the endovascular treatment of thoracic aortic transections, off-label use of commercially available abdominal aortic extension cuffs can be successfully used to treat these injuries. One of the main limitations of the use of abdominal devices for the treatment of thoracic aortic pathology has been insufficient device length for accessing the thoracic aorta via a femoral approach. Indeed, in our series, inadequate device length required a retroperitoneal iliac artery exposure to access the aorta in three cases.
Various measures can be undertaken to estimate the device length required to treat lesions of the thoracic aorta including measuring the distance from the sternal notch to the inguinal crease and using the preoperative CT scan to estimate vessel length. In our experience, these techniques accurately determined whether the device length would be sufficient. A cutoff of 61 cm (length of Excluder delivery system) was used to determine which lesions could be addressed percutaneously as opposed to those that required a retroperitoneal iliac cutdown. There were no conversions to an open approach after the initial decision had been made to proceed percutaneously. In the future, availability of commercial devices designed specifically for the treatment of thoracic aortic lesions will likely use longer delivery sheaths and will obviate the need to approach these lesions in a retroperitoneal fashion.
For the most part, the patient population suffering thoracic aortic transection in the setting of blunt trauma is younger than patients who develop aneurysmal degeneration or dissection of the thoracic aorta. The long-term outcome and durability of these endovascular devices has yet to be proven. In the meantime, extensive follow-up should include annual CT angiography. Whereas our mean follow-up was close to 2 years after the procedure, CT scans have demonstrated no evidence of endoleak, stent migration, or late pseudoaneurysm formation. However, the fact that these devices are placed within an otherwise normal aorta makes the occurrence of late complications seen after endovascular repair of abdominal aortic aneurysms less likely.
In the current report, we have demonstrated that commercially available endovascular aortic extension cuffs designed for use within the abdominal aorta can be used successfully to treat traumatic thoracic aortic transections. Our small series demonstrated technical success, safety, and midterm durability of these devices. Avoidance of systemic anticoagulation in the setting of patients with multiple injuries is one of the main advantages of the endovascular technique over open repair. Despite limitations of delivery system lengths, percutaneous repair of these lesions is possible in the majority of cases; however, whereas initial results are encouraging, close long-term follow-up is required until the durability of these devices can be demonstrated definitively.
